Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast - Abbott Laboratories ( NYSE:ABT )
On Wednesday, Abbott Laboratories ABT reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Organic sales growth for the underlying base business was 8.2%, led by double-digit growth in Medical Devices.
| Ticker |
Sentiment |
Impact |
|
SSTK
|
Neutral
|
12 %
|
|
ABT
|
Somewhat Bearish
|
34 %
|
